Literature DB >> 18221426

Trends of type 1 diabetes in Karachi, Pakistan.

A Samad Shera1, Zahid Miyan, Abdul Basit, Asma Maqsood, Mohammad Yakoob Ahmadani, Asher Fawwad, Mahwish Riaz.   

Abstract

OBJECTIVE: Our study aims to assess the presentation, prevalence, and associations of acute and chronic complications in subjects with type 1 diabetes mellitus (T1DM) at their first visit to outpatient departments. STUDY DESIGN AND
SETTING: Study was carried out at two centers, Diabetic Association of Pakistan and WHO Collaborating Centre and Baqai Institute of Diabetology and Endocrinology, Karachi. Records of 591 T1DM subjects divided into two groups were studied. Group 1 (62.1%, n = 367) includes patients with known T1DM and group 2 (n = 224, 37.9%), newly diagnosed T1DM. Clinical features [polyuria, polydipsia, polyphagia, history of weight loss, and history of diabetic ketoacidosis (DKA)] were recorded. Biochemical parameters including fasting plasma glucose, 2-h postprandial plasma glucose, hemoglobin A1c, urinary ketones, and proteinuria were recorded. Arterial blood gases was done in suspected cases of DKA.
RESULTS: In group 1, male predominance was seen (57.8 vs. 42.2%). Mean age at presentation was 19.1 +/- 10 yr. Mean duration of diabetes was 16 +/- 9 yr. Two percent subjects presented with DKA, while 21% had a history of DKA. Among the subjects with >10 yr of diabetes, 20.1% had hypertension, 5.5% had nephropathy, 2.9% had neuropathy, and 7.7% had retinopathy. In group 2, 224 T1DM subjects were identified, with mean age of 17 +/- 11 yr. Equal number of males (50.9%) and females (49.1%) were diagnosed at their first presentation. Most subjects (40.8%, n = 91) diagnosed between 11 and 20 yr of age presented with polyuria (81.3%), polydipsia (77.2%), polyphagia (56.7%), and weight loss (79.5%). Ketonuria was positive in 4.9%, while 5.8% presented with DKA.
CONCLUSIONS: This is the first study in Pakistan to assess the mode of presentation and prevalence of acute and chronic complications in T1DM. Larger scale prospective studies are needed to have more detailed informative data.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221426     DOI: 10.1111/j.1399-5448.2007.00309.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  6 in total

1.  Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients.

Authors:  Aysha Karim Kiani; Sidrah Jahangir; Sidrah Jahngir; Peter John; Attya Bhatti; Asima Zia; Xingbin Wang; F Yesim Demirci; M Ilyas Kamboh
Journal:  Immunogenetics       Date:  2015-04-24       Impact factor: 2.846

2.  Clinical features, biochemistry and HLA-DRB1 status in youth-onset type 1 diabetes in Pakistan.

Authors:  Asher Fawwad; Denira Govender; Mohammad Yakoob Ahmedani; Abdul Basit; Julie Ann Lane; Steven John Mack; Mark Alvin Atkinson; Clive Henry Wasserfall; Graham David Ogle; Janelle Annette Noble
Journal:  Diabetes Res Clin Pract       Date:  2019-01-30       Impact factor: 5.602

3.  Relationship of C-peptide levels to duration of Type 1 diabetes - A study from Sindh, Pakistan.

Authors:  Asher Fawwad; Nazish Waris; Saima Askari; Graham Ogle; Muhammad Yakoob Ahmedani; Abdul Basit
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

4.  Seasonal variation and severity of Diabetic Ketoacidosis in patients at a tertiary care hospital in Pakistan.

Authors:  Bakht Babar; Azizul Hasan Aamir
Journal:  Pak J Med Sci       Date:  2022 May-Jun       Impact factor: 2.340

5.  Frequency, severity and risk indicators of retinopathy in patients with diabetes screened by fundus photographs: a study from primary health care.

Authors:  Saleh Memon; Shahid Ahsan; Qamar Riaz; Abdul Basit; Sikandar Ali Sheikh; Asher Fawwad; A Samad Shera
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

6.  Factors associated with non-adherence to insulin in patients with type 1 diabetes.

Authors:  Musarrat Riaz; Abdul Basit; Asher Fawwad; Muhammad Yakoob Ahmedani; Zahara Ali Rizvi
Journal:  Pak J Med Sci       Date:  2014-03       Impact factor: 1.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.